Gabriele Madonna

18PUBLICATIONS
85CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsInnate immunityGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 05, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik

|Jan 21, 2025
Role of the androgen receptor in melanoma aggressiveness.

Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone

|Aug 10, 2024
Innate Immune Cells in Melanoma: Implications for Immunotherapy.

Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino

|Mar 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.

Domenico Liguoro, Rachele Frigerio, Arianna Ortolano

|Nov 16, 2023
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.

Sara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima

|May 11, 2023
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients.

Domenico Galati, Serena Zanotta, Mariaelena Capone

Pageof 3

Frequent Collaborators

14 joint publications

Paolo Antonio Ascierto

11 joint publications

Mariaelena Capone

3 joint publications

Domenico Mallardo

3 joint publications

Lucia Festino